000 01749 a2200529 4500
005 20250515121036.0
264 0 _c20080930
008 200809s 0 0 eng d
022 _a1476-5594
024 7 _a10.1038/onc.2008.157
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChekenya, M
245 0 0 _aThe progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.
_h[electronic resource]
260 _bOncogene
_cSep 2008
300 _a5182-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens
_xphysiology
650 0 4 _aApoptosis
_xphysiology
650 0 4 _aBrain Neoplasms
_xmetabolism
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aEnzyme Activation
650 0 4 _aGlioma
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIntegrins
_xphysiology
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aProteoglycans
_xphysiology
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aTumor Necrosis Factor-alpha
_xphysiology
700 1 _aKrakstad, C
700 1 _aSvendsen, A
700 1 _aNetland, I A
700 1 _aStaalesen, V
700 1 _aTysnes, B B
700 1 _aSelheim, F
700 1 _aWang, J
700 1 _aSakariassen, P Ø
700 1 _aSandal, T
700 1 _aLønning, P E
700 1 _aFlatmark, T
700 1 _aEnger, P Ø
700 1 _aBjerkvig, R
700 1 _aSioud, M
700 1 _aStallcup, W B
773 0 _tOncogene
_gvol. 27
_gno. 39
_gp. 5182-94
856 4 0 _uhttps://doi.org/10.1038/onc.2008.157
_zAvailable from publisher's website
999 _c17965042
_d17965042